Gabapentinoids - For a Healthy Belgium

Key figures
Data
Graphics
Comments

PRESCRIBERS
Main prescribers: General practitioners	71.71%
INSURED CONSUMERS
% of insured consumers	1.76%
Median age	64 years
Max/min ratio of the median age (by district)	1.10
Percentage of women	60.35%
Ratio Preferential scheme/General scheme	2.36
Coefficient of variation (2022)	20.57
Max/min ratio of % of insured consumers (by district)	2.20
CONSUMPTION
Annual consumption (DDD)	27,543,250
Consumption of DDD (per 100,000 insured persons)	239,321.30
% DDD issued outside the insurance (approximate)	4.15%
Average annual consumption per insured consumer (DDD)	136.34
% of insured consumers with > 3 times the average consumption	7,00%
Coefficient of variation 2013-2015	20.13
Coefficient of variation 2020-2022	17.82
Trend 2013-2022	10.25%
Trend 2013-2019	13.38%
Trend 2019-2022	4.25%
DIRECT EXPENDITURE (DDD)
Annual expenditure charged to the insurance	16,983,365€
Average annual expenditure per insured person	1.48 €
Average patient share per insured consumer	19.11%
Max/min ratio of expenditure per insured person (by disctrict)	1.96
% “Low-cost” medication	99.98%
Trend 2013-2022	-2.92%
Trend 2019-2022	0.35%

On this table, when a statistical test has been performed, the data showing a significant difference is displayed on an yellow background, otherwise on a grey background.